- Report
- June 2021
- 77 Pages
Global
From €4531EUR$4,950USD£3,851GBP
- Report
- January 2024
- 200 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Report
- June 2021
Global
From €2563EUR$2,800USD£2,178GBP
€3662EUR$4,000USD£3,112GBP
- Report
- March 2024
- 163 Pages
Global
From €2289EUR$2,500USD£1,945GBP
From €2289EUR$2,500USD£1,945GBP
- Report
- April 2022
- 120 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Report
- October 2021
- 120 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Report
- February 2025
- 85 Pages
India
From €3204EUR$3,500USD£2,723GBP
- Report
- February 2025
- 85 Pages
India
From €3204EUR$3,500USD£2,723GBP
From €3204EUR$3,500USD£2,723GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3204EUR$3,500USD£2,723GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3204EUR$3,500USD£2,723GBP
From €3204EUR$3,500USD£2,723GBP
- Report
- September 2024
- 82 Pages
Japan
From €3204EUR$3,500USD£2,723GBP
- Report
- April 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2024
- 180 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2024
- 183 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2024
- 180 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2024
- 175 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2024
- 172 Pages
Global
From €4119EUR$4,500USD£3,501GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more